XOS.NASDAQXos, INC

Form 4: Xos Director Sells Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


Xos Director Michael Richardson sold a total of 8,608 shares of common stock over three days in December 2025, pursuant to a pre-arranged 10b5-1 trading plan.

Summary

  • Michael Paul Richardson, a Director of Xos, Inc. (XOS), reported sales of common stock.
  • The transactions were executed under a Rule 10b5-1 trading plan adopted by Mr. Richardson on September 16, 2025.
  • On December 18, 2025, 2,870 shares were sold at a weighted average price of $2.0547 per share.
  • On December 19, 2025, 2,869 shares were sold at a weighted average price of $2.0366 per share.
  • On December 22, 2025, 2,869 shares were sold at a weighted average price of $2.141 per share.
  • Following these transactions, Mr. Richardson beneficially owns 87,264 shares of common stock, which includes 62,377 unvested Restricted Stock Units (RSUs).

Sentiment

Score: 5

Explanation: The sentiment is neutral. The filing reports routine insider stock sales executed under a pre-arranged 10b5-1 plan, which is a common practice and does not inherently signal positive or negative company performance or outlook.

Negatives

  • Director selling shares could be perceived negatively by some investors, although the sales were pre-planned under a Rule 10b5-1 plan.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

Insider sales, particularly those executed under a Rule 10b5-1 trading plan, are a routine disclosure in the public markets. Such plans allow insiders to sell a predetermined number of shares at a predetermined time or price, helping to avoid accusations of trading on material non-public information. These sales are generally viewed as less indicative of management's sentiment about the company's future prospects compared to unplanned, open-market sales.

Stakeholder Impact

  • Shareholders: May observe a minor increase in selling pressure or a slight perception shift due to director sales, though mitigated by the 10b5-1 plan.

Key Dates

DateDescription
09/16/2025Date Rule 10b5-1 trading plan was adopted by the Reporting Person.
12/18/2025Transaction date for the sale of 2,870 shares of common stock.
12/19/2025Transaction date for the sale of 2,869 shares of common stock.
12/22/2025Transaction date for the sale of 2,869 shares of common stock and filing date of the Form 4.

Keywords

Xos, XOS, Form 4, insider trading, stock sale, director, 10b5-1 plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.